These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 11344647

  • 1. [Dyslipoproteinemia and diabetes mellitus].
    Vaverková H.
    Vnitr Lek; 2000 Sep; 46(9):532-8. PubMed ID: 11344647
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of dyslipoproteinaemia in diabetes mellitus.
    Dean JD, Durrington PN.
    Diabet Med; 1996 Apr; 13(4):297-312. PubMed ID: 9162604
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic goals in hyperlipoproteinemia].
    Ceska R.
    Vnitr Lek; 2000 Sep; 46(9):555-8. PubMed ID: 11344652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].
    Mudríková T, Tkác I, Takác M.
    Vnitr Lek; 1994 Apr; 40(4):250-4. PubMed ID: 8184588
    [Abstract] [Full Text] [Related]

  • 8. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
    Steinmetz A.
    Diabetes Metab Res Rev; 2008 Apr; 24(4):286-93. PubMed ID: 18273835
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. What is the most effective strategy for managing diabetic dyslipidaemia?
    Reasner CA.
    Atheroscler Suppl; 2005 Sep; 6(3):21-7. PubMed ID: 16054442
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E, Baccara-Dinet M, Eschwege E.
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 19. Diabetes, hypertension and hyperlipidaemia.
    Durrington PN.
    Postgrad Med J; 1993 Dec; 69 Suppl 1():S18-25; discussion S25-9. PubMed ID: 8497453
    [Abstract] [Full Text] [Related]

  • 20. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.